Responsible OfficeResearch Integrity
Effective Date of Current Version17-Aug-2026
Originally Issued18-Nov-2024
Last Revised17-Aug-2026
AuthorsN. Coll
Who Should Read This Policy
  • All university faculty and staff, regardless of title or position, responsible for the design, conduct or reporting of Lehigh University research or sponsored programs.
  • College deans, associate deans, administrators, and department chairs. 
  • Staff in research administration roles. 
  • Trustees and Officers responsible for crafting and oversight of other university policies on conflicts of interest. 
  • Members of the Conflict of Interest Review Committee (CIRC).
Introduction

Lehigh University recognizes that financial conflicts of interest may exist in an academic research environment. The university’s commitment to unbiased design, conduct, and reporting of research requires the university to identify and manage real or apparent related Financial Conflicts of Interest (fCOI). This policy facilitates compliance with all applicable laws related to fCOIs in research. The university provides corresponding administrative processes and guidelines to enable the university and its investigators to meet their obligations under these laws.  

Policy Statement

This policy applies to all Investigators participating in or planning to participate in Lehigh University research and sponsored programs. It outlines the investigator disclosure requirements that enable the university to identify, manage, and report fCOIs related to university research and sponsored programs. 

Disclosure Submission and Review Procedures 

Investigators are required to submit disclosures:

  • Annually,
  • no later than at the time of award setup for research or sponsored programs, and
  • within 30 days of discovering or acquiring a new Significant Financial Interest (SFI).

Investigators must amend disclosures within 30 days of any material changes in circumstances affecting an existing SFI.

DOE awards issued on or after August 17, 2026 are subject to the requirements outlined in the "Disclosure Requirements and Timing" section of Appendix H.

The Office of Research Integrity is designated to solicit and review related disclosures for determination of an fCOI. An Investigator may be involved in making the determination of whether a Significant Financial Interest (SFI) is Related to their research or sponsored programs. See the Definitions section below for a full definition of Related. The university offers detailed guidance for determining if an SFI is Related.

Prior to the expenditure of funds on a sponsored program, the Office of Research Integrity:

  • reviews all Investigators’ disclosures,
  • makes a reasonable determination as to whether a disclosed SFI could directly and significantly affect the design, conduct, or reporting of the sponsored program (i.e. an fCOI exists), and
  • in consultation with the Vice Provost for Research (VPR), the Conflict of Interest Review Committee (CIRC), and others as needed, determine whether the fCOI is manageable and a Management Plan is required in order for the research activity to proceed. See Appendix A – Conflict Management for details on that process. 
Significant Financial Interests

Anything that meets the following definition of a Significant Financial Interest (SFI) is required to be disclosed per the processes outlined above:

  1. For a domestic or foreign publicly traded External Entity:
    1. The total value of any Remuneration received by the Investigator or their Immediate Family in the twelve months preceding the disclosure and 
    2. The value of any Equity Interest in the entity as of the date of disclosure that together exceeds $5,000.
  2. For a domestic or foreign non-publicly traded External Entity:
    1. The total value of any Remuneration received by the Investigator or their Immediate Family in the twelve months preceding that exceeds $5,000 or
    2. The Investigator or their Immediate Family holds any Equity Interest, regardless of its value.
  3. Intellectual Property Income: Upon its receipt, any income received by the Investigator or their Immediate Family related to intellectual property rights and interests, except when that income is paid by Lehigh University to the Investigator or their Immediate Family. 
  4. Management Positions: Any management position held by the Investigator, such as director, officer, partner, president, vice-president, or trustee, in any External Entity in the twelve months preceding the disclosure. 
  5. Foreign Talent Recruitment Programs: Participation in or support received by the Investigator from a Foreign Talent Recruitment Program in the twelve months preceding the disclosure.
  6. Travel Expenses: Any travel that is reimbursed, paid, or otherwise sponsored on the Investigator’s behalf, related to the Investigator’s university responsibilities, that is not otherwise disclosed in current and pending or other support disclosures (see exception below).

The following are not SFIs:

  1. Travel reimbursed or sponsored by:  
    1. the university,
    2. a U.S. federal, state, or local government agency,
    3. a U.S. non-profit institution of higher education as defined at 20 U.S.C. 1001(a), or
    4. an academic teaching hospital, medical center, or research institute affiliated with an institution of higher education in the U.S. 
  2. Salaries, royalties, or other Remuneration paid by the university to the Investigator, including intellectual property rights assigned to the institution and agreements to share in royalties related to such rights.  
  3. Income from investment vehicles, e.g., mutual funds and retirement accounts, provided the Investigator does not directly control the investment decisions made in these vehicles. 
  4. Income from:
    1. U.S. federal, state, or local government agency, 
    2. a non-profit U.S. institution of higher education as defined at 20 U.S.C. 1001(a), or
    3. an academic teaching hospital, medical center, or research institute affiliated with an institution of higher education in the U.S. 

In exchange for:

  • seminars, teaching lectures, or teaching engagements, or
  • service on advisory committees or review panels
Definitions 
Equity InterestStock, stock options, or other ownership interests. The value of equity in publicly-traded entities is determined through reference to public prices or other reasonable measures of fair market value.
External EntityAny non-federal entity other than Lehigh University or its components.
Financial Conflict of Interest (fCOI)An fCOI exists when the university reasonably determines that an Investigator’s Significant Financial Interest (SFI) is Related to university research or sponsored programs and could directly and significantly affect its design, conduct, or reporting.
Foreign Talent Recruitment ProgramAny program, position, or activity that includes compensation in the form of cash, in-kind compensation, including research funding, promised future compensation, complimentary foreign travel, things of non de minimis value, honorific titles, career advancement opportunities, or other types of remuneration or consideration directly provided by a foreign country at any level (national, provincial, or local) or their designee, or an entity based in, funded by, or affiliated with a foreign country, whether or not directly sponsored by the foreign country, to an individual, whether directly or indirectly stated in the arrangement, contract, or other documentation at issue
Immediate FamilyThe Investigator’s spouse, domestic partner, dependent children, and any persons residing in their household.
InvestigatorLehigh University personnel, regardless of title or position, responsible for the design, conduct or reporting of Lehigh University research or sponsored programs. This includes the project director or principal investigator, and any other senior/key personnel identified in a grant application, progress report, or any other report related to university research or sponsored programs.
Management PlanA binding agreement between the university and the conflicted investigator that details the conditions or restrictions imposed on the conflicted investigator in the conduct of subject research.
Related

A Significant Financial Interest (SFI) is Related when a reasonable person could determine that the SFI:

  • could be affected by the Lehigh research,
  • is in an entity whose financial interest could be affected by the research, or 
  • could directly and significantly affect the design, conduct or reporting of the Lehigh research.
RemunerationSalary and any payment for services not otherwise identified as salary. E.g. consulting fees, honoraria, paid authorship.
Sponsored Program
  • Programs funded by an external sponsor through a grant, contract, or agreement with the university, including but not limited to research, education, testing, and outreach.
  • Programs funded through Lehigh University’s internal grants program administered through the office of the Vice Provost for Research (VPR).
Contacts

Lehigh University Office of Research Integrity

incoi@lehigh.edu

References

CFR Title 2 – Grants and Agreements, Subtitle A – OMB Guidance for Federal Financial Assistance, Chapter II – OMB Guidance, Part 200 – Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards, Subpart B – General Provisions, §200.112 Conflict of interest.

CFR Title 42 – Public Health, Chapter I – Public Health Service, Department of Health and Human Services, Subchapter D - Grants, Part 50 – Policies of General Applicability, Subpart F – Promoting Objectivity in Research

2 CFR part 910, subpart C, Conflicts of Interest, Conflicts of Commitment, Organizational Conflicts of Interest, and Other Matters of Concern (91 FR 43511, July 16, 2026)

National Science Foundation. Proposal and Award Policies and Procedures Guide (PAPPG). Effective May 20, 2024. NSF 24-1. OMB Control Number 3145-0058. Part II: Award, Administration, and Monitoring of NSF Assistance Award. Chapter IX – Recipient Standards. A – Conflict of Interest Policies

Appendicies

When a Management Plan is required, the Office of Research Integrity:

  • Notifies the Investigator and their Department Chair/supervisor that the Related research cannot proceed until a Management Plan is approved by the CIRC,
  • Works with the Office of Research and Sponsored Programs (ORSP) to determine if there are any sponsor notification requirements,
  • Works with the conflicted investigator to develop a Management Plan, and
  • Coordinates CIRC review of the Management Plan.

The CIRC reviews the recommended Management Plan and:

  • votes whether to approve the recommended Management Plan as presented or with modifications, or 
  • requests additional information, including as-needed from campus administrative offices, General Counsel, and Department Chairs.

Based on the CIRC’s review, the Office of Research Integrity works with the conflicted investigator, and their Department Chair/supervisor as necessary, to finalize the Management Plan, and to promulgate binding Management Plans once final. Compliance with the Management Plan is monitored on an ongoing basis until the conflict is eliminated.

Until required Management Plans are approved by the CIRC:

  • ORSP does not establish accounts/indexes
  • Funds are not expended
  • IRB review is not completed

A conflicted investigator may appeal CIRC decisions by promptly submitting a written request for reconsideration. The CIRC has the authority to review and affirm their previous decision or to amend the Management Plan. As an ex-officio member of the CIRC, the VPR (or designee) may recommend that the CIRC alter or remove a requirement, but cannot require the CIRC to do so. In all cases, the VPR may add requirements to a Management Plan at his or her discretion. The Office of Research Integrity promptly informs the conflicted investigator of the results of the appeal. 

For subrecipients under a prime award to Lehigh University, the university will document in a written subrecipient agreement that:

  • Certifies that the subrecipient has its own fCOI policy compliant with:
    • 2 CFR 200.112 and 113 (Uniform Guidance), or alternatively:
      • For PHS awards: 42 CFR Part 50 and 45 CFR part 94
      • For DOE awards: 2 CFR part 910, subpart C," and read Appendix B subject to the "Subrecipient Requirements" section of Appendix H
      • For NSF awards: Proposal and Award Policies and Procedures Guide (PAPPG) (NSF 24-1) Part II: Chapter IX.A
  • Includes time periods to meet the disclosure and/or fCOI reporting requirements of Lehigh University to a sponsor.

Except under the special circumstances described below, subrecipients that do not have their own compliant fCOI policy are considered ineligible to be subrecipients for awards until they develop and implement a compliant policy.

Under special circumstances, subrecipients without their own compliant fCOI policy may agree to comply with Lehigh University’s policy only if all subrecipient personnel disclose to Lehigh University at the proposal stage that they have no Related SFIs. In this situation:

  • the subrecipient remains obligated to disclose annually,
  • if the subrecipient discovers or acquires a new Related SFI during the course of the award, the subrecipient must notify the university as soon as possible, and within 30 days of discovering or acquiring the new SFI, and
  • the university retains the right to modify or end the subaward agreement.

The university provides initial and ongoing fCOI reports: 

  • To PHS as required pursuant to 42 CFR §50.604-606
  • To DOE as required pursuant to 2 CFR 910.240 and 910.260," and read Appendix C subject to the "Reporting to DOE" section of Appendix H
  • To NSF as required pursuant to the applicable Proposal & Award Policies & Procedures Guide (PAPPG) 

Investigators who have not completed required disclosures prior to deadlines established by the university are prohibited from submitting new sponsored program proposals. Existing awards for sponsored programs involving a noncompliant Investigator will not be distributed.

Investigators subject to a Management Plan are responsible for complying with the terms and conditions set forth in the Management Plan. Failures to adhere to the terms and conditions of a Management Plan are referred to the CIRC for determination if the failure constitutes noncompliance with this policy. A determination of noncompliance will be cause for appropriate sanctions , at the discretion of the CIRC. Where such a failure is not remedied, the noncompliance may be reported to the pertinent sponsor and referred to the Provost and further to appropriate university review committees for further action. Any academic misconduct or termination proceedings are conducted in accordance with applicable university policies.

If the university identifies an SFI that was not disclosed in a timely manner by an Investigator or, for whatever reason, was not previously reviewed by the university during an ongoing sponsored program, the Office of Research Integrity shall, within 60 days:

  • Review the SFI
  • Determine whether it is related to the Investigator’s active sponsored programs, and
  • Determine whether an fCOI exists

If this review identifies an fCOI, the Office of Research Integrity will work with the conflicted Investigator to implement, on at least an interim basis, a Management Plan that specifies the actions that have been, and will be, taken to manage the fCOI going forward.

When the university identifies an fCOI that was not identified or managed in a timely manner, the university shall, within 120 days of the determination of noncompliance, complete a retrospective review of the conflicted Investigator’s activities and the subject PHS-funded research project(s) to determine whether any PHS-funded research, or portion thereof, conducted during the time period of the noncompliance was biased in the design, conduct, or reporting of such research. The PHS sponsor will be promptly notified if bias is found and a required Mitigation report submitted, in accordance with to PHS 42 CFR §50.605(a)(3)(iii).

The university complies with the additional requirements pursuant to PHS 42 CFR §50.605(b) regarding unmanaged or unreported fCOIs in PHS-sponsored clinical research designed to evaluate the safety or efficacy of a drug, medical device, or treatment.

Annually, and at award setup for each sponsored program award, the university informs each Investigator of:

  • This policy
  • The Investigator’s disclosure responsibilities, and
  • The applicable federal regulations

Investigators funded by PHS awards issued or DOE awards issued on or after December 20, 2021 but before August 17, 2026 must also complete training as designated by the Office of Research and Sponsored Programs (ORSP) and provide evidence of successful completion to ORSP:

  • Prior to engaging in subject awards and thereafter at least every four years,
  • At the direction of the Office of Research Integrity, when this policy changes in a manner that affects Investigator requirements,
  • When Investigators are newly appointed to a subject award, or
  • If the university finds that the Investigator is noncompliant with this policy or the terms and conditions of a Management Plan.

DOE awards issued on or after August 17, 2026 are subject to the requirements in the "Training" section of Appendix H.

All fCOI-related records are maintained in accordance with university policy and sponsors’ requirements. Disclosures and records of actions taken to manage fCOIs are securely maintained by the Office of Research and Sponsored Programs (ORSP) and the Office of Research Integrity for at least three years from the date that the final expenditure report is submitted to the sponsor, or from the dates specified in the applicable regulation, including from the date of the resolution of any government action involving those records, whichever is longer.

The university will exert reasonable efforts to keep all transactions related to disclosures secure. The information supplied will be released internally only to the extent necessary to comply with this policy.

Federal sponsors have the right to review fCOI-related records. The university will inform Investigators of any request from a federal sponsor to release these records.

This policy is posted on Lehigh University’s website.

Information concerning identified fCOIs held by senior/key personnel (defined by applicable federal regulations) on federally sponsored awards will be made available prior to the expenditure of funds as follows:

  • Within 5 calendar days of a written request
  • Including the minimum elements as provided in the applicable regulation
  • Including current information that has been updated at least annually and within sixty days of a newly identified fCOI
  • Remaining available for three years from the date the information was most recently updated

Purpose

This Appendix establishes the additional requirements that apply to Lehigh University Investigators and administrative offices in connection with DOE financial assistance, so that the University's practices satisfy 2 CFR part 910, subpart C, effective August 17, 2026. It also introduces two concepts not previously addressed in the policy: conflict of commitment and organizational conflict of interest.

Scope, Applicability, and Order of Precedence

This Appendix applies to any Lehigh University application to, or award from, DOE or NNSA that is submitted or issued on or after August 17, 2026, and to every Covered Individual who plans to participate in or is participating in the resulting project, including work funded by recipient cost share included in the approved budget.

This Appendix applies to each non-Federal entity subrecipient under a Lehigh DOE prime award, as set out in the Subrecipient Requirement section below.

Where a DOE program office tailors the requirements of 2 CFR part 910, subpart C for an individual applying in an individual capacity, or where a Notice of Funding Opportunity (NOFO) or award term imposes requirements beyond those stated here, the tailored or additional requirements control. DOE has stated it will not tailor these requirements where the applicant is a university or research facility.

The complete Policy on Financial Conflicts Related to Research and Sponsored Programs remains in full force (“the/this policy”). Where this Appendix imposes a shorter deadline, a broader disclosure obligation, or a more frequent training interval than the policy, this Appendix controls for DOE-funded work. Nothing in this Appendix relieves an Investigator of any obligation under the policy or under Public Health Service (PHS), National Science Foundation (NSF), or other applicable sponsor requirements.

Definitions Applicable to DOE Awards

The following definitions from 2 CFR 910.200 apply to DOE awards and supplement the Definitions section of the policy. Where a term below conflicts with a policy definition, the definition below governs for DOE-funded work.

Term

Definition

Conflict of Commitment (COC)

A situation in which an individual accepts or incurs conflicting obligations, foreign or domestic, between or among multiple employers or other entities. This includes conflicting commitments of time and effort, such as obligations to dedicate time in excess of University or DOE policies or commitments, and other conflicting obligations such as obligations to improperly share information with, or withhold information from, an employer or DOE. Situations that may give rise to a COC include current or pending employment; positions, appointments, or affiliations, including titled academic, professional, or institutional appointments, whether or not remunerated and whether full-time, part-time, or voluntary (including adjunct, visiting, or honorary positions); and participation in or applications to foreign government-sponsored talent recruitment or similar programs.

Conflict of Interest (COI)

A situation in which a Covered Individual, or the spouse or child of a Covered Individual, has a Significant Financial Interest or financial relationship, whether with a domestic or foreign entity, that could directly and significantly affect the design, conduct, reporting, or funding of a project or other award-related activities. Examples include holding an executive or director position or equity above the applicable threshold in a company that stands to benefit from award-related activities; receiving consulting payments or payment for services from such a company; and intellectual property rights or royalties whose value may be affected by the outcome of award-related activities.

Covered Individual

Any individual, regardless of title or position, who (a) contributes in a substantive, meaningful way to the development or execution of the scope of work of a project funded or proposed for funding by DOE, and (b) is designated as a Covered Individual by DOE. DOE designates as Covered Individuals any principal investigator (PI), project director (PD), co-PI, co-PD, or project manager; any individual, regardless of title, functionally performing in one of those roles; and any person designated in the applicable NOFO or in the terms and conditions of the award. Submission of a current and pending support disclosure and/or a biosketch or resume for a person constitutes DOE's designation of that person as a Covered Individual.

Financial Interest

Anything of monetary value, whether or not the value is readily ascertainable.

Other Support

All resources made available to a Covered Individual in support of or related to their professional research (including basic and fundamental research), development, demonstration, or deployment efforts, including resources provided directly to the individual rather than through the University, and regardless of whether they have monetary value (for example, in-kind office or laboratory space, equipment, supplies, or personnel). This includes resource or financial support from all foreign and domestic entities, including gifts provided with or without terms or conditions, financial support for laboratory personnel, and the participation of students, visiting researchers, and visiting scholars supported by other sources of funding.

Organizational Conflict of Interest (OCI)

As defined at 2 CFR 200.318(c)(2), applicable where the University conducts a procurement or other transaction with a parent, affiliate, or subsidiary organization that is not a state government, local government, or Indian Tribe. For Lehigh, this includes: 

  1. Ben Franklin Technology Partners of Northeastern Pennsylvania
  2. Centennial School
  3. Manufactures Resource Center / Lehigh Valley
  4. Small Business Development Center 

Project

The interdependent activities funded wholly or in part under the DOE award, with a defined start and end point and objectives described in an application or approved scope. Activities funded with recipient cost share included in the approved budget are part of the Project.

Significant Financial Interest (SFI)

As defined at 2 CFR 910.200. The DOE definition is substantively consistent with the SFI categories in the policy, with the clarifications in Section 3.1 below.

Reconciling the Policy SFI definition with 2 CFR 910.200

Persons whose interests are captured. DOE requires consideration of the interests of the Covered Individual and the Covered Individual's spouse and dependent children. The policy's definition of Immediate Family is broader and continues to apply; disclosing the broader set satisfies DOE.

Non-publicly traded entities. For a foreign or domestic non-publicly traded entity, an SFI exists where remuneration not otherwise disclosed as current, pending, or Other Support received in the preceding twelve months exceeds $5,000 in the aggregate, or where any equity interest is held regardless of value.

Intellectual property. Intellectual property rights and interests (for example, patents, copyrights) are an SFI upon receipt of income related to those rights and interests.

No de minimis threshold for travel or intellectual property. Investigators must disclose all reimbursed or sponsored travel and all intellectual property interests, regardless of value.

Travel exclusions. Travel reimbursed or sponsored by the following are not SFIs:

  • a Federal, state, or local government agency of the United States; 
  • a domestic institution of higher education; or 
  • a domestic research institute affiliated with a domestic institution of higher education. 

Investigators should note that the DOE exclusion does not extend to academic teaching hospitals or medical centers that are not so affiliated; where the policy exclusion is broader, the narrower DOE exclusion applies to DOE-funded work.

Excluded interests. The following are not SFIs:

  • Salary, royalties, or other remuneration paid by the University to a currently employed or appointed Covered Individual (including intellectual property rights assigned to the University and royalty-sharing agreements); 
  • income from investment vehicles such as mutual funds and retirement accounts where the individual does not directly control investment decisions; 
  • income from seminars, lectures, or teaching engagements sponsored by a U.S. Federal, state, or local government agency, a domestic institution of higher education, or an affiliated domestic research institute; and 
  • income from service on advisory committees or review panels for those same entities.
Identification and Designation of Covered Individuals

As prime applicant, the University is responsible for assessing the Covered Individual definition against each person listed on a DOE application, and for identifying any such person to DOE for designation if not already designated by operation of 2 CFR 910.200.

The Office of Research and Sponsored Programs (ORSP) will make this assessment as part of proposal review. Because submission of a current and pending support disclosure or a biosketch/resume for a person operates as DOE designation, any person for whom either document is submitted is a Covered Individual.

The Covered Individual population may be broader than the policy's Investigator population. It reaches any individual — including individuals at the master's or baccalaureate level — who contributes in a substantive, meaningful way to the development or execution of the scope of work, together with any person named in the NOFO or award terms. PIs must identify such personnel to ORSP at proposal preparation.

Disclosure Requirements and Timing

The following requirements supplement the Disclosure Submission and Review Procedures section of the policy for DOE-funded work.

  • Disclosure before application submission. Every Covered Individual must have provided all required COI and COC disclosures to the University no later than the time the application is submitted to DOE. This is earlier than the policy's award-setup deadline. Investigators must complete disclosures in LIRA before ORSP submits the proposal.
  • Individuals added after application. Where the University seeks to add a Covered Individual after application, that individual must complete the required disclosures before participating in the project.
  • Annual updates. Each Covered Individual participating in a DOE award must update disclosures annually.
  • New conflicts — 15 days. Each Covered Individual must report any new actual, apparent, or potential COI or COC as soon as practicable and in no event later than 15 days after it arises. This deadline replaces the policy's 30-day deadline for DOE-funded work.
  • Conflicts of commitment are separately disclosable. Covered Individuals must disclose conflicting obligations of the kind described in the COC definition in Section 3, including:
    • outside employment and pending employment; 
    • titled academic, professional, or institutional appointments, whether or not compensated and whether full-time, part-time, or voluntary, including adjunct, visiting, and honorary positions; 
    • participation in or applications to foreign government-sponsored talent recruitment or similar programs; and 
    • any obligation that would require improperly sharing information with, or withholding information from, the University or DOE. 

Note that disclosure of participation in a Foreign Talent Recruitment Program under the policy and under the University's Policy: Foreign Talent Recruitment Programs does not by itself satisfy the broader COC disclosure obligation.

  • Travel disclosures. For reimbursed or sponsored travel, disclosures must state, at a minimum, the purpose of the trip, the identity of the sponsor or organizer, the destination, and the duration. The Office of Research Integrity will determine whether further information is needed, including a determination or disclosure of monetary value, to assess whether the travel constitutes a COI or COC.
  • Foreign entity due diligence. Each Covered Individual is expected to maintain a reasonable understanding of the entities with which they do business and to exercise due diligence in determining whether an interest presents an actual, apparent, or potential COI or COC.
Required Certification Statement

Each disclosure submitted under this Appendix must be signed and dated by the Covered Individual and must include the certification statement set out in Appendix A to 2 CFR part 910, subpart C. The certification is incorporated into the LIRA disclosure workflow. The certification records the individual's acknowledgment that: 

  • the disclosure is required to obtain Federal funding; 
  • the information is true, complete, and accurate to the best of the individual's knowledge and belief; 
  • false, fictitious, or fraudulent information, misrepresentations, half-truths, or omissions of material fact may subject the individual to criminal, civil, or administrative penalties under 18 U.S.C. 287, 1001, and 1031 and 31 U.S.C. 3729–3733 and 3801–3812; 
  • the statements are material to the Government's funding decision, and; 
  • the individual has a continuing responsibility to update disclosures during the period of performance.
Review, Determination, and Management

Designated officials. The Office of Research Integrity is the designated University office that solicits and reviews COI and COC disclosures from Covered Individuals under 2 CFR 910.230(b)(1).

Determination. The Office of Research Integrity reviews all Covered Individuals' disclosures to determine whether an actual, apparent, or potential COI or COC exists. For DOE purposes:

  • an actual conflict exists where an SFI or financial relationship exists that could directly and significantly affect the design, conduct, reporting, or funding of the project or other award-related activities;
  • potential conflict exists where such an interest or relationship may arise in the future, for example where an individual applies for outside employment, and;
  • an apparent conflict exists where a conflict may appear to exist to a reasonable outside observer even though no actual or potential conflict exists.

Management measures. Where a conflict is identified, the Office of Research Integrity, in consultation with the Vice Provost for Research and the Conflict of Interest Review Committee (CIRC) under Appendix A of the policy, will determine the actions taken and to be taken to eliminate or, where appropriate, manage or reduce the conflict. Measures may include:

  • public disclosure of the conflict when the project is presented or published;
  • disclosure directly to participants in projects involving human subjects;
  • appointment of an independent monitor or oversight committee capable of protecting the purpose, design, conduct, and reporting of the project against bias;
  • modification of the project plan; 
  • change of personnel or personnel responsibilities, or disqualification of personnel from all or part of the project; 
  • reduction or elimination of the financial interest or the commitment, and/or; 
  • severance of the relationship creating the conflict.

Management Plans. Management Plans for DOE-funded work are developed, approved, monitored, and appealed under Appendix A of the policy, and must address COCs as well as COIs.

Reporting to DOE

This Section supplements Appendix C of the policy. ORSP, in coordination with the Office of Research Integrity, submits the following to DOE in writing.

  • Unmanageable conflicts. Any actual, apparent, or potential COI or COC — including any reported to the University by a subrecipient — that cannot be eliminated or appropriately managed or reduced under University policy.
  • All foreign-government-related conflicts. Any actual, apparent, or potential COI or COC — including any reported by a subrecipient — involving any foreign government, its instrumentalities, or any other entity owned, funded, or otherwise controlled by a foreign government, together with the measures taken to eliminate, manage, or reduce it. This obligation applies whether or not the conflict is manageable.
  • Timing and placement. Conflicts requiring disclosure to DOE must be clearly and explicitly disclosed in the application itself. Where a Covered Individual is added after application, the conflict must be disclosed in writing to DOE before that individual participates in the project.
  • Expanded reporting on request. Where required by the NOFO or award terms, the University will disclose all Covered Individuals' COIs and COCs, including those the University has determined are appropriately managed or reduced.
  • Supporting documentation. On DOE request, the University will provide associated disclosures, documentation demonstrating how a conflict was managed or reduced, and sufficient information for DOE to understand the nature and extent of the conflict and to assess whether the University's actions are sufficient.
  • Annual COI/COC reports. For any conflict previously reported on an ongoing DOE-funded project, the University will provide an annual COI/COC report addressing the status of the conflict and any changes to the Management Plan. The report must state whether the conflict is still being managed or remains unmanaged or unmanageable, or explain why the conflict no longer exists. Annual reports continue for the duration of the project period, including extensions with or without funds, in the time and manner required by the award terms.
  • Routine or on-request submissions. DOE may require the University to submit all or some Covered Individuals' disclosures routinely or on request, including: 
    • as part of monitoring compliance; 
    • in the event of bankruptcy or other legal winding down of the University; 
    • upon acquisition of the University by a foreign entity, including a foreign entity obtaining a controlling interest, or; 
    • as otherwise provided in 2 CFR part 200 and part 910.
  • Noncompliance by a Covered Individual. Where the University becomes aware that a Covered Individual failed to comply with University COI or COC policy or with a Management Plan, the University will promptly notify DOE in writing of the failure and of the corrective action taken or to be taken. DOE declined to adopt a 60-day reporting window; corrective action need not be completed before the report is made. Determinations of noncompliance under Appendix D of the policy must therefore be routed to ORSP for prompt DOE notification rather than held pending completion of remedial steps.
Subrecipient Requirements

This Section supplements Appendix B of the policy for DOE prime awards.

  • The written subrecipient agreement must establish whether the recipient's (Lehigh's) or the subrecipient's COI and COC policy applies to the subrecipient's Covered Individuals.
  • Where the subrecipient's policy applies, the subrecipient must certify in the agreement that its policy complies with 2 CFR part 910, subpart C. If the subrecipient cannot so certify, the agreement must state that the subrecipient's Covered Individuals are subject to Lehigh's COI and COC policy as supplemented by this Appendix.
  • Where the subrecipient's policy applies, the agreement must specify time periods for the subrecipient to report all identified COIs and COCs to the University, sufficient to allow the University to meet its DOE reporting deadlines, including the 15-day new-conflict deadline and prompt noncompliance notification.
  • Where Lehigh's policy applies, the agreement must specify time periods for the subrecipient to submit all Covered Individuals' disclosures to the University, sufficient to allow the University to meet its review, management, and reporting obligations.
  • For DOE prime awards, the policy's treatment of subrecipients without a compliant policy is modified: such a subrecipient is not ineligible, and the "special circumstances" limitation in Appendix B (requiring all subrecipient personnel to attest at the proposal stage that they have no Related SFIs) does not apply. Instead, the subrecipient's Covered Individuals are subject to Lehigh's policy under paragraph 2 above, and must complete the same disclosures, certification, and training required of Lehigh Covered Individuals. The University retains the right to modify or end the subaward agreement.
  • Appendix B of the policy is amended to cite 2 CFR part 910, subpart C in place of the December 20, 2021 DOE Interim Conflict of Interest Policy.
Organizational Conflicts of Interest

This Section establishes a requirement not addressed in the policy.

  • Written standards of conduct. As they pertain to university subsidiary organizations, the Office of the Research Integrity maintains written standards of conduct covering OCIs as defined at 2 CFR 200.318(c)(2). The University does not have a parent or affiliated organization. 
  • Prohibition. Where the effects of a potential or actual OCI cannot be avoided, eliminated, or mitigated, the anticipated procurement or other transaction must not be made using DOE funds or cost share funds.
  • Disclosure and timing. The University must disclose any potential or actual OCI to DOE in writing within 15 business days of learning of the conflict. Disclosure must be made in the application for financial assistance and before engaging in a procurement or other transaction to acquire services or property using DOE funds with a subsidiary organization.
  • Required content. An OCI disclosure must include, at a minimum: 
    • the name, address, and website (as applicable) of the entity presenting the OCI; 
    • the relationship between the University and that entity; 
    • the nature, anticipated value, and basis for the anticipated procurement or other transaction; 
    • the basis for the University's determination regarding the existence of an OCI; and
    • how the University will avoid, eliminate, or mitigate the OCI.
  • Scope beyond procurement. These requirements extend to transactions other than formal procurements that acquire goods or services through different mechanisms or authorities. Procurement Services will route any proposed transaction using DOE funds or DOE cost share with a Lehigh subsidiary organization to the Office of Research Integrity for OCI screening before the transaction is committed.
Training

This Section supplements Appendix E of the policy.

  • Each Covered Individual must complete COI and COC training before engaging in a project funded under a DOE award, and refresher training at least every two years. The two-year interval replaces the policy's four-year interval for DOE-funded work.
  • To satisfy this requirement, each Covered Individual must complete the CITI Research Security training, as currently required annually for DOE investigators. Additionally, as currently required for all Lehigh University faculty and staff engaged in externally sponsored research, each Covered Individual must annually review the policy on financial conflicts of interest related to research, which includes this Appendix. 
  • In addition, a Covered Individual must complete training within 30 days of any of the following: the University revises its COI or COC policies or procedures in a manner affecting Covered Individual responsibilities; the Covered Individual is new to the University; or the University finds that the Covered Individual is not in compliance with its COI and COC policy or an applicable Management Plan. The Office of Research Integrity will identify when these instances occur and implement the requirement.
Noncompliance, Remedies, and Enforcement

This Section supplements Appendix D of the policy. Investigators should understand that where the University fails to disclose a COI or COC, or fails to sufficiently manage or mitigate one, DOE may require action to eliminate or mitigate the conflict to a risk level acceptable to DOE and, absent that, may determine that the award no longer effectuates program goals or agency priorities and terminate it; may determine that the circumstances disqualify an entity or individual from all or part of an award; or may reject an application. DOE may inquire at any time before, during, or after an award into any Covered Individual's disclosures and the University's review of and response to them, whether or not the University found a conflict, and may impose specific award conditions under 2 CFR 200.208 or take actions under 2 CFR 200.339.

Where a Covered Individual knowingly fails to disclose required information, DOE may: 

  • reject an application; 
  • suspend or terminate an award; 
  • discontinue or de-obligate funding for the individual or the University, temporarily or permanently; 
  • refer the University for suspension or debarment proceedings; 
  • refer the failure to the DOE Office of Inspector General or Federal law enforcement; 
  • report the University in the Federal Awardee Performance and Integrity Information System (FAPIIS); or 
  • take actions under 2 CFR 200.339 or other applicable law. False, fictitious, or fraudulent information, or omission of a material fact, in any disclosure, report, or record required under 2 CFR part 910, subpart C may carry criminal, civil, or administrative penalties.

Failure to disclose an OCI before engaging in a covered procurement or other transaction may result in the costs of that procurement or transaction being disallowed.

Records, Access, and Availability of the Policy
  • Policy availability. The University must make its written COI and COC policy available within five business days following any request for it. The policy and this Appendix are posted publicly. The Office of Research Integrity responds to direct requests within five business days.
  • Records and DOE access. The University must submit, or permit on-site review of, all records pertinent to compliance with 2 CFR part 910, subpart C. DOE will maintain the confidentiality of records of financial interests to the extent permitted by law. Records are retained under Appendix F of the policy.
  • Suspected fraud. Where fraud, misrepresentation, or related misconduct is suspected in relation to a disclosure submitted to DOE, DOE may refer the matter to its Office of Inspector General. The University will cooperate with any such inquiry.
Conforming Changes to the Policy

Effective August 17, 2026, the Policy is amended as follows:

  • References section — replace the citation to the Department of Energy Interim Conflict of Interest Policy (December 20, 2021) with: 2 CFR part 910, subpart C, Conflicts of Interest, Conflicts of Commitment, Organizational Conflicts of Interest, and Other Matters of Concern (91 FR 43511, July 16, 2026).
  • Appendix B (Subrecipient Requirements) — replace "For DOE awards: the December 20, 2021 Department of Energy Interim Conflict of Interest Policy" with "For DOE awards: 2 CFR part 910, subpart C," and read Appendix B subject to Section 9 of this Appendix.
  • Appendix C (Sponsor Reporting Requirements) — replace "To DOE as required pursuant to Section V(b) of the December 20, 2021 Department of Energy Interim Conflict of Interest Policy" with "To DOE as required pursuant to 2 CFR 910.240 and 910.260," and read Appendix C subject to Section 8 of this Appendix.
  • Appendix E (Training Requirements) — the reference to DOE awards issued on or after December 20, 2021 continues to apply to awards issued before August 17, 2026; awards issued on or after that date are subject to Section 11 of this Appendix.
  • Disclosure Submission and Review Procedures — the 30-day deadline for reporting new or materially changed SFIs remains in effect generally, subject to the 15-day DOE deadline in Section 5.4 of this Appendix for DOE-funded work.